OMICS Technologies For Predictive Modeling of Infectious Diseases Program

by: Michael Saunders

The National Institute of Health, more commonly referred to as NIH, is a federal government agency operating within the United States Department of Health and Human Services that is primarily responsible for supporting the country's biomedical and health-related research studies.

The grants and initiatives of the NIH are all geared towards the successful realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the OMICS Technologies For Predictive Modeling of Infectious Diseases Program.

The program is specifically designed to aid in the development and validation of predictive models of infectious disease initiation, progression and outcomes while employing integrated datasets generated from a combination of "omics" technologies.

OMICS technologies refer to the process involving rapid and accurate measurements tens and hundreds of thousands of data points (i.e., DNA sequences, gene expression levels) in a short period of time.

At present, there four major types of "omics" technologies that are being used to gather data, these include genomics, transcriptomics, proteomics, metabolomics.

  (continued...)

OMICS Technologies For Predictive Modeling of Infectious Diseases Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---

HIV Innovations for Improved Patient Outcomes for Priority Populations Program
The United States Agency for International Development in South Africa has recently established the HIV Innovations for Improved Patient Outcomes for Priority Populations Program wherein it intends to solicit applications coming from local organizations which are interested in heading the implementation of a five-year plan centered on the program in focus.

---

Pilot Studies of Innovative Treatments in Mental Disorders Project
The National Institutes of Health has recently collaborated with the National Institutes of Mental Health (NIMH) to establish the Pilot Studies of Innovative Treatments in Mental Disorders Program.

---